ARTICLE | Company News
BioAlliance, Daewoong Pharmaceutical deal
April 7, 2014 7:00 AM UTC
BioAlliance granted Daewoong exclusive rights to develop and commercialize herpes product Sitavig acyclovir Lauriad in South Korea. Daewoong is responsible for securing regulatory approval in South ...